221 related articles for article (PubMed ID: 22721391)
1. Biology and medicinal chemistry approaches towards various apoptosis inducers.
Vyas VK; Chintha C; Pandya MR
Anticancer Agents Med Chem; 2013 Mar; 13(3):433-55. PubMed ID: 22721391
[TBL] [Abstract][Full Text] [Related]
2. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
[TBL] [Abstract][Full Text] [Related]
3. TRAIL receptor signalling and modulation: Are we on the right TRAIL?
Mahalingam D; Szegezdi E; Keane M; de Jong S; Samali A
Cancer Treat Rev; 2009 May; 35(3):280-8. PubMed ID: 19117685
[TBL] [Abstract][Full Text] [Related]
4. Targeting TRAIL in the treatment of cancer: new developments.
Lim B; Allen JE; Prabhu VV; Talekar MK; Finnberg NK; El-Deiry WS
Expert Opin Ther Targets; 2015; 19(9):1171-85. PubMed ID: 26004811
[TBL] [Abstract][Full Text] [Related]
5. Targeted manipulation of apoptosis in cancer treatment.
Call JA; Eckhardt SG; Camidge DR
Lancet Oncol; 2008 Oct; 9(10):1002-11. PubMed ID: 18760670
[TBL] [Abstract][Full Text] [Related]
6. Manipulating the apoptotic pathway: potential therapeutics for cancer patients.
Bates DJ; Lewis LD
Br J Clin Pharmacol; 2013 Sep; 76(3):381-95. PubMed ID: 23782006
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in targeting regulators of apoptosis in cancer cells for therapeutic gain.
Taylor K; Micha D; Ranson M; Dive C
Expert Opin Investig Drugs; 2006 Jun; 15(6):669-90. PubMed ID: 16732718
[TBL] [Abstract][Full Text] [Related]
8. Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy.
Kim R; Tanabe K; Uchida Y; Emi M; Inoue H; Toge T
Cancer Chemother Pharmacol; 2002 Nov; 50(5):343-52. PubMed ID: 12439591
[TBL] [Abstract][Full Text] [Related]
9. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists.
Ashkenazi A
Nat Rev Drug Discov; 2008 Dec; 7(12):1001-12. PubMed ID: 18989337
[TBL] [Abstract][Full Text] [Related]
10. Anti-apoptotic mechanisms of drug resistance in cancer.
Wilson TR; Johnston PG; Longley DB
Curr Cancer Drug Targets; 2009 May; 9(3):307-19. PubMed ID: 19442051
[TBL] [Abstract][Full Text] [Related]
11. The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling.
Toth C; Funke S; Nitsche V; Liverts A; Zlachevska V; Gasis M; Wiek C; Hanenberg H; Mahotka C; Schirmacher P; Heikaus S
Cell Commun Signal; 2017 May; 15(1):16. PubMed ID: 28464919
[TBL] [Abstract][Full Text] [Related]
12. Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development.
Jain MV; Paczulla AM; Klonisch T; Dimgba FN; Rao SB; Roberg K; Schweizer F; Lengerke C; Davoodpour P; Palicharla VR; Maddika S; Łos M
J Cell Mol Med; 2013 Jan; 17(1):12-29. PubMed ID: 23301705
[TBL] [Abstract][Full Text] [Related]
13. Multifaceted targeting in cancer: the recent cell death players meet the usual oncogene suspects.
Drosopoulos K; Pintzas A
Expert Opin Ther Targets; 2007 May; 11(5):641-59. PubMed ID: 17465723
[TBL] [Abstract][Full Text] [Related]
14. Targeting death receptors to fight cancer: from biological rational to clinical implementation.
Mocellin S
Curr Med Chem; 2010; 17(25):2713-28. PubMed ID: 20586721
[TBL] [Abstract][Full Text] [Related]
15. A novel prohibitin-binding compound induces the mitochondrial apoptotic pathway through NOXA and BIM upregulation.
Moncunill-Massaguer C; Saura-Esteller J; Pérez-Perarnau A; Palmeri CM; Núñez-Vázquez S; Cosialls AM; González-Gironès DM; Pomares H; Korwitz A; Preciado S; Albericio F; Lavilla R; Pons G; Langer T; Iglesias-Serret D; Gil J
Oncotarget; 2015 Dec; 6(39):41750-65. PubMed ID: 26497683
[TBL] [Abstract][Full Text] [Related]
16. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
[TBL] [Abstract][Full Text] [Related]
17. The TRAIL apoptotic pathway in cancer onset, progression and therapy.
Johnstone RW; Frew AJ; Smyth MJ
Nat Rev Cancer; 2008 Oct; 8(10):782-98. PubMed ID: 18813321
[TBL] [Abstract][Full Text] [Related]
18. Combinatorial application of nucleic acid-based agents targeting protein kinases for cancer treatment.
Spänkuch B; Strebhardt K
Curr Pharm Des; 2008; 14(11):1098-112. PubMed ID: 18473857
[TBL] [Abstract][Full Text] [Related]
19. A Cell's Fate: An Overview of the Molecular Biology and Genetics of Apoptosis.
Cavalcante GC; Schaan AP; Cabral GF; Santana-da-Silva MN; Pinto P; Vidal AF; Ribeiro-Dos-Santos Â
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450613
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic targeting of apoptosis pathways in cancer.
Ziegler DS; Kung AL
Curr Opin Oncol; 2008 Jan; 20(1):97-103. PubMed ID: 18043263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
